ICRA Limited Schedules Board Meeting on May 21, 2026 to Approve FY26 Financial Results and Dividend

ICRA Limited has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Thursday, May 21, 2026. The intimation was filed on May 5, 2026, pursuant to Regulation 29 and other applicable regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

Board Meeting Agenda

The board meeting has been convened to address key financial and corporate governance matters for the financial year 2025-26. The following items are on the agenda:

Agenda Item:	Details
Financial Results (Standalone):	Audited results for the quarter and year ended March 31, 2026
Financial Results (Consolidated):	Audited results for the quarter and year ended March 31, 2026
Dividend Consideration:	Recommendation of dividend, if any, on equity shares for FY 2025-26
Meeting Date:	Thursday, May 21, 2026

Regulatory Compliance

The intimation has been issued in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by S. Shakeb Rahman, Company Secretary & Compliance Officer of ICRA Limited, and submitted to both BSE Limited and the National Stock Exchange of India Limited.

ICRA Limited is headquartered at Building No. 8, 2nd Floor, Tower A, DLF Cyber City, Phase II, Gurugram - 122002, Haryana, with its registered office at B - 710, Statesman House, 148, Barakhamba Road, New Delhi - 110001.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.48%	-0.50%	+5.87%	-15.86%	-7.86%	+59.57%

TTK Healthcare Limited has published a newspaper notice regarding the Securities and Exchange Board of India (SEBI) circular on the special window for transfer and dematerialisation of physical securities. The company disclosed this information to stock exchanges on April 17, 2026, in compliance with Regulation 30.

SEBI Circular Implementation

The special window has been established pursuant to SEBI Circular HO/38/13/11(2)2026-MIRSD-POD/3750/2026 dated January 30, 2026, focusing on "Ease of Doing Investment - Special Window for Transfer and Dematerialisation of Physical Securities."

Parameter	Details
Window Period	February 5, 2026 to February 4, 2027
Duration	One year
Eligible Securities	Physical securities sold/purchased before April 1, 2019
Transfer Mode	Demat mode only
Lock-in Period	One year from transfer registration date

Publication and Disclosure Details

TTK Healthcare published the notice in Business Standard (English Version) across four editions on Friday, April 17, 2026. The company also posted the information on its LinkedIn page and made it available on the company website at www.ttkhealthcare.com under the Investor Relations section.

Key Features of the Special Window

The facility covers physical securities that were sold or purchased prior to April 1, 2019, including transfer requests that were previously submitted but rejected, returned, or unattended due to deficiency in documents or processing issues. During this period, transferred securities will be issued only in demat mode with a mandatory one-year lock-in period.

Exclusions	Details
Disputed Cases	Cases involving disputes between transferor and transferee
IEPF Transfers	Securities transferred to Investor Education and Protection Fund

Contact Information for Shareholders

Shareholders interested in utilizing this facility can contact the company's Registrar and Transfer Agent, M/s Data Software Research Co. Pvt. Ltd. For assistance, shareholders can write to investorcare@ttkhealthcare.com or ttk@dsrc.com . The notice was signed by Gowry A Jaishankar, DGM – Legal & Company Secretary.